Diabetes and Technology: The Role of Artificial Intelligence, Continuous Glucose Monitors, and Insulin Pumps in Modern Care View PDF

Research on diabetes and technology has emerged as a critical area of inquiry due to the increasing global prevalence of diabetes and the substantial burden it places on individuals and healthcare systems [1-4]. Over the past decades, diabetes management has evolved from traditional insulin injections and self-monitoring of blood glucose (type 1 diabetes (T1D) and type 2 diabetes (T2D)) to advanced digital ecosystems integrating CGMs, insulin pumps, and AI algorithms [5- 8] (Table 1). These technological advancements have demonstrated improvements in glycemic control, reduction in hypoglycemia, and enhanced quality of life for patients [14, 27]. With over 463 million people affected worldwide and healthcare costs exceeding hundreds of billions annually, the integration of technology in diabetes care is both a practical necessity and a promising frontier [1, 32].

Recent literature underscores the rapid development and application of these tools in improving patient outcomes and personalizing care. AI has emerged as a transformative force in diabetes management, leveraging big data analysis to enable precise sub-typing and tailored treatment strategies [42]. Its capabilities extend to early detection of complications such as diabetic retinopathy, thereby facilitating timely interventions [42]. When combined with CGM technology, AI supports remote monitoring and the development of novel glucose metrics and algorithms, enhancing the accuracy and responsiveness of glucose control [42]. Notably, AI-driven closed-loop insulin pumps can automatically adjust insulin infusion rates, thereby increasing the time blood glucose levels remain within target ranges and reducing hypoglycemia risks [42, 43].

Technological advancements in glucose monitoring devices, particularly CGMs, have been instrumental in data-driven diabetes management [44-48]. The integration of CGMs with insulin pumps has led to the development of closed-loop systems, often referred to as artificial pancreas systems, which automate insulin delivery based on real-time glucose readings [5, 49]. These systems exemplify the convergence of sensor technology and AID, representing a significant leap toward personalized and autonomous diabetes care [5, 49]. Insulin pumps themselves have seen innovations aimed at enhancing their functionality and user understanding. Efforts to demystify pump mechanics and control principles through cost-effective, modular platforms aim to improve clinician and patient familiarity with these devices [50]. Additionally, the connectivity between insulin pumps and CGMs, although promising, faces current limitations that hinder seamless integration [10]. Despite these challenges, the potential for AID systems to revolutionize care remains substantial, with ongoing research focusing on overcoming connectivity barriers [10, 51].

The role of telehealth and smart devices further complements these technological advances [52-55]. Telehealth platforms incorporate devices such as glucose meters, CGMs, insulin pumps, and smartphones to facilitate remote monitoring and management [56]. This integration supports continuous oversight and timely adjustments, aligning with the broader trend toward digital and personalized diabetes care [49]. Overall, the literature highlights a trajectory toward increasingly automated, data-driven, and personalized diabetes management systems. AI enhances diagnostic and treatment precision, while innovations in CGMs and insulin pumps-particularly their integration into closed-loop systems—are central to this evolution. Despite existing challenges, these technological advancements collectively aim to improve glycemic control, reduce complications, and enhance quality of life for individuals with diabetes [5, 42, 49, 51].

Diabetes management has undergone a significant transformation in recent years, largely due to advancements in technology. The integration of AI, CGMs, and insulin pumps has revolutionized the way healthcare providers and patients manage diabetes. This article explores the role of these technologies in modern diabetes care, highlighting their benefits, challenges, and implications for patient outcomes.